Effect of Latitude Bias in Entry Angle on Ground Casualty Risk from Naturally Decaying Space Objects

An improvement to the long-term estimation of ground casualties from naturally decaying space objects is the refinement to the distribution of entry angle at the entry interface as a function of latitude. Previous analyses were based on an assumed "small angle," typically -0.1, and entry interface at the equator. This study expands on work by Bacon and Matney that indicated there is significant latitude bias in the location of reentries, compared to prior assumptions of equal temporal probability. A new model has been developed, which describes the distribution of entry angle as a function of orbital inclination and argument of latitude. This model has been used to generate inputs for ODPOs certified reentry survivability software, Object Reentry Survival Analysis Tool (ORSAT). These new results are compared with the prior standard model to assess the magnitude of the effects on reentry casualty risk

Genomic and Epigenomic Instability, Fragile Sites, Schizophrenia and Autism

Increasing evidence links genomic and epigenomic instability, including multiple fragile sites regions to neuropsychiatric diseases including schizophrenia and autism. Cancer is the only other disease associated with multiple fragile site regions, and genome and epigenomic instability is a characteristic of cancer. Research on cancer is far more advanced than research on neuropsychiatric disease; hence, insight into neuropsychiatric disease may be derived from cancer research results. Towards this end, this article will review the evidence linking schizophrenia and other neuropsychiatric diseases (especially autism) to genomic and epigenomic instability, and fragile sites. The results of studies on genetic, epigenetic and environmental components of schizophrenia and autism point to the importance of the folate-methionine-transulfuration metabolic hub that is diseases also perturbed in cancer. The idea that the folate-methionine-transulfuration hub is important in neuropsychiatric is exciting because this hub present novel targets for drug development, suggests some drugs used in cancer may be useful in neuropsychiatric disease, and raises the possibility that nutrition interventions may influence the severity, presentation, or dynamics of disease